These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10486500)

  • 1. The use of human immunodeficiency virus postexposure prophylaxis after successful artificial insemination.
    Bloch M; Carr A; Vasak E; Cunningham P; Smith D
    Am J Obstet Gynecol; 1999 Sep; 181(3):760-1. PubMed ID: 10486500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
    Katzenstein TL; Dickmeiss E; Aladdin H; Hede A; Nielsen C; Nielsen H; Jørgensen LB; Gerstoft J
    Ann Intern Med; 2000 Jul; 133(1):31-4. PubMed ID: 10877737
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV postexposure prophylaxis: new recommendations.
    Patrick DM
    CMAJ; 1997 Jan; 156(2):233-4. PubMed ID: 9012728
    [No Abstract]   [Full Text] [Related]  

  • 4. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.
    Hirsch M; Steigbigel R; Staszewski S; Mellors J; Scerpella E; Hirschel B; Lange J; Squires K; Rawlins S; Meibohm A; Leavitt R
    J Infect Dis; 1999 Sep; 180(3):659-65. PubMed ID: 10438352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of three maintenance regimens given after three months of induction therapy with zidovudine, lamivudine, and indinavir in previously untreated HIV-1-infected patients. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team.
    Pialoux G; Raffi F; Brun-Vezinet F; Meiffrédy V; Flandre P; Gastaut JA; Dellamonica P; Yeni P; Delfraissy JF; Aboulker JP
    N Engl J Med; 1998 Oct; 339(18):1269-76. PubMed ID: 9791142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
    Kibayashi K; NG'walali PM; Tsunenari S
    Nihon Hoigaku Zasshi; 1998 Apr; 52(2):163-4. PubMed ID: 9711070
    [No Abstract]   [Full Text] [Related]  

  • 8. Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection.
    Smith D; Berrey MM; Robertson M; Mehrotra D; Markowitz M; Perrin L; Clumeck N; Lazzarin A; Burckhardt B; Weber R; Corey L; Cooper DA
    J Infect Dis; 2000 Sep; 182(3):950-4. PubMed ID: 10950796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.
    Gulick RM; Mellors JW; Havlir D; Eron JJ; Gonzalez C; McMahon D; Richman DD; Valentine FT; Jonas L; Meibohm A; Emini EA; Chodakewitz JA
    N Engl J Med; 1997 Sep; 337(11):734-9. PubMed ID: 9287228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability of postexposure prophylaxis with zidovudine, lamivudine, and nelfinavir for human immunodeficiency virus infection.
    Rabaud C; Bevilacqua S; Beguinot I; Dorvaux V; Schuhmacher H; May T; Canton P
    Clin Infect Dis; 2001 May; 32(10):1494-5. PubMed ID: 11317252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle-stick injuries and HIV infection: a surgeon's personal experience and review of postexposure prophylaxis. St. Paul's Ocular AIDS Group.
    Hurwitz JJ; Fine N; Rachlis AR
    Can J Ophthalmol; 1999 Jun; 34(4):195-203. PubMed ID: 10396655
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 13. Human immunodeficiency virus transmission through artificial insemination.
    Chiasson MA; Stoneburner RL; Joseph SC
    J Acquir Immune Defic Syndr (1988); 1990; 3(1):69-72. PubMed ID: 2293645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercholesterolemia in a health care worker receiving thyroxine after postexposure prophylaxis for human immunodeficiency virus infection.
    Nerad JL; Kessler HA
    Clin Infect Dis; 2001 Jun; 32(11):1635-6. PubMed ID: 11340537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team.
    Havlir DV; Marschner IC; Hirsch MS; Collier AC; Tebas P; Bassett RL; Ioannidis JP; Holohan MK; Leavitt R; Boone G; Richman DD
    N Engl J Med; 1998 Oct; 339(18):1261-8. PubMed ID: 9791141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elective cesarean delivery plus short-course lamivudine and zidovudine for the prevention of mother-to-child transmission of human immunodeficiency virus type 1.
    Panburana P; Sirinavin S; Phuapradit W; Vibhagool A; Chantratita W
    Am J Obstet Gynecol; 2004 Mar; 190(3):803-8. PubMed ID: 15042018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV transmission through donor artificial insemination.
    Araneta MR; Mascola L; Eller A; O'Neil L; Ginsberg MM; Bursaw M; Marik J; Friedman S; Sims CA; Rekart ML
    JAMA; 1995 Mar; 273(11):854-8. PubMed ID: 7869555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
    Mueller BU; Sleasman J; Nelson RP; Smith S; Deutsch PJ; Ju W; Steinberg SM; Balis FM; Jarosinski PF; Brouwers P; Mistry G; Winchell G; Zwerski S; Sei S; Wood LV; Zeichner S; Pizzo PA
    Pediatrics; 1998 Jul; 102(1 Pt 1):101-9. PubMed ID: 9651421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric AIDS--is now not the right time to act?
    Matchaba PT; Chapanduka ZC
    S Afr Med J; 1997 Oct; 87(10):1343-5. PubMed ID: 9472245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.